These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
280 related articles for article (PubMed ID: 21040672)
1. [Incidence, pathology and clinical course and symptoms of neuroendocrine gastrointestinal tumours]. Federspiel BH; Hansen CP; Vainer B; Hasselby JP; Bardram L; Knigge U Ugeskr Laeger; 2010 Oct; 172(43):2946-50. PubMed ID: 21040672 [TBL] [Abstract][Full Text] [Related]
2. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach. Kuiper P; Verspaget HW; Overbeek LI; Biemond I; Lamers CB Neth J Med; 2011 Jan; 69(1):14-20. PubMed ID: 21325696 [TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors. Pape UF; Jann H; Müller-Nordhorn J; Bockelbrink A; Berndt U; Willich SN; Koch M; Röcken C; Rindi G; Wiedenmann B Cancer; 2008 Jul; 113(2):256-65. PubMed ID: 18506737 [TBL] [Abstract][Full Text] [Related]
4. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Niederle MB; Hackl M; Kaserer K; Niederle B Endocr Relat Cancer; 2010 Dec; 17(4):909-18. PubMed ID: 20702725 [TBL] [Abstract][Full Text] [Related]
5. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Klöppel G Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112 [TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification. Anlauf M Horm Metab Res; 2011 Nov; 43(12):825-31. PubMed ID: 22105474 [TBL] [Abstract][Full Text] [Related]
7. Neuroendocrine tumors of the digestive tract: impact of new classifications and new agents on therapeutic approaches. Oberg K Curr Opin Oncol; 2012 Jul; 24(4):433-40. PubMed ID: 22510940 [TBL] [Abstract][Full Text] [Related]
8. Digestive Neuroendocrine Tumor Distribution and Characteristics According to the 2010 WHO Classification: a Single Institution Experience in Lebanon. Kourie HR; Ghorra C; Rassy M; Kesserouani C; Kattan J Asian Pac J Cancer Prev; 2016; 17(5):2679-81. PubMed ID: 27268650 [TBL] [Abstract][Full Text] [Related]
9. Nordic Guidelines 2010 for diagnosis and treatment of gastroenteropancreatic neuroendocrine tumours. Janson ET; Sørbye H; Welin S; Federspiel B; Grønbaek H; Hellman P; Mathisen O; Mortensen J; Sundin A; Thiis-Evensen E; Välimäki MJ; Oberg K; Knigge U Acta Oncol; 2010 Aug; 49(6):740-56. PubMed ID: 20553100 [TBL] [Abstract][Full Text] [Related]
10. [Diagnostic criteria and classification of gastro-intestinal pancreatic endocrine tumors]. Capella C; Uccella S; Albarello L; Feltri M; La Rosa S Minerva Endocrinol; 2001 Sep; 26(3):103-10. PubMed ID: 11753231 [TBL] [Abstract][Full Text] [Related]
11. [Neuroendocrine tumours of pancreas and gastrointestinal tract]. Tsimmerman IaS Klin Med (Mosk); 2009; 87(12):7-13. PubMed ID: 20135878 [TBL] [Abstract][Full Text] [Related]
12. [Neuroendocrine tumors of the gastroenteropancreatic system--reevaluation using the Capella classification]. Brüwer M; Pahlov-Nejad T; Herbst H; Senninger N; Schürmann G Zentralbl Chir; 2003 Aug; 128(8):656-62. PubMed ID: 12931261 [TBL] [Abstract][Full Text] [Related]
13. [Diagnostic and therapeutic guidelines for gastrointestinal neuroendocrine tumors (recommended by the Polish Network of Neuroendocrine Tumors)]. Kos-Kudła B; Bolanowski M; Handkiewicz-Junak D; Jarzab B; Królicki L; Krzakowski M; Kunikowska J; Nasierowska-Guttmejer A; Nowak A; Rydzewska G; Starzyńska T; Szawłowski A; Endokrynol Pol; 2008; 59(1):41-56. PubMed ID: 18335400 [TBL] [Abstract][Full Text] [Related]
14. The epidemiology of gastroenteropancreatic neuroendocrine tumors. Lawrence B; Gustafsson BI; Chan A; Svejda B; Kidd M; Modlin IM Endocrinol Metab Clin North Am; 2011 Mar; 40(1):1-18, vii. PubMed ID: 21349409 [TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Kos-Kudła B; Blicharz-Dorniak J; Handkiewicz-Junak D; Jarząb B; Jarząb M; Kunikowska J; Kuśnierz K; Król R; Królicki L; Krzakowski M; Nasierowska-Guttmejer A; Nowakowska-Duława E; Patkowski W; Szawłowski AW; ; Endokrynol Pol; 2013; 64(6):418-43. PubMed ID: 24431116 [TBL] [Abstract][Full Text] [Related]
16. The prevalence and relevance of adrenal masses in patients with sporadic gastroenteropancreatic neuroendocrine tumours (GEP-NET). Kanakis G; Kamp K; Tsiveriotis K; Feelders RA; Zormpala A; de Herder WW; Kaltsas G Clin Endocrinol (Oxf); 2013 Jun; 78(6):950-6. PubMed ID: 22970733 [TBL] [Abstract][Full Text] [Related]
17. Imaging of neuroendocrine tumours (CT/MR/US). Rockall AG; Reznek RH Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):43-68. PubMed ID: 17382265 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic and therapeutic guidelines for gastro-entero-pancreatic neuroendocrine neoplasms (recommended by the Polish Network of Neuroendocrine Tumours). Kos-Kudła B; Blicharz-Dorniak J; Strzelczyk J; Bałdys-Waligórska A; Bednarczuk T; Bolanowski M; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Foltyn W; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Krzakowski M; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Lipiński M; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nawrocki S; Nowakowska-Duława E; Pilch-Kowalczyk J; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zemczak A; Zgliczyński W; Zieniewicz K Endokrynol Pol; 2017; 68(2):79-110. PubMed ID: 28597909 [TBL] [Abstract][Full Text] [Related]
19. Incidence, patterns of care and prognostic factors for outcome of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): results from the National Cancer Registry of Spain (RGETNE). Garcia-Carbonero R; Capdevila J; Crespo-Herrero G; Díaz-Pérez JA; Martínez Del Prado MP; Alonso Orduña V; Sevilla-García I; Villabona-Artero C; Beguiristain-Gómez A; Llanos-Muñoz M; Marazuela M; Alvarez-Escola C; Castellano D; Vilar E; Jiménez-Fonseca P; Teulé A; Sastre-Valera J; Benavent-Viñuelas M; Monleon A; Salazar R Ann Oncol; 2010 Sep; 21(9):1794-1803. PubMed ID: 20139156 [TBL] [Abstract][Full Text] [Related]
20. The novel WHO 2010 classification for gastrointestinal neuroendocrine tumours correlates well with the metastatic potential of rectal neuroendocrine tumours. Jernman J; Välimäki MJ; Louhimo J; Haglund C; Arola J Neuroendocrinology; 2012; 95(4):317-24. PubMed ID: 22327359 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]